BP000138-C045: Recombinant Human Interleukin-16 (IL-16) Protein
Source: E. coli-derived.
The ED50 as determined by its ability to chemoattract human CD4+ T lymphocytes using a concentration range of 10.0-100.0 ug/ml, corresponding to a Specific Activity greater than 1.0 x 104 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000138-CYT-142: Recombinant Human Interleukin-16 (121 a.a.) Protein
Source: E. coli-derived.
Fully biologically active when compared to standard. Determined by its ability to chemoattract human CD4+ T-Lymphocytes using a concentration range of 50.0-100.0 ug/ml.
Purity: > 97.0% by RP-HPLC and SDS-PAGE.BP000138-CYT-153: Recombinant Rhesus Macaque Interleukin-16 (IL-16) Protein
Source: E. coli-derived.
Fully biologically active when compared to standard. Determined by its ability to chemoattract human CD4+ T-Lymphocytes using a concentration range of 50.0-100.0 ug/ml corresponding to a Specific Activity of 10,000-20,000 IU/mg.
Purity: > 98.0% by SDS-PAGE.BP000138-CYT-536: Recombinant Human Interleukin-16 (130 a.a.) Protein
Source: E. coli-derived.
The ED50 as determined by its ability to chemoattract human CD4+ T lymphocytes using a concentration range of 10-100 ng/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000138-CYT-559: Recombinant Mouse Interleukin-16 (IL-16) Protein
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000138-CYT-562: Recombinant Human Interleukin-16 (IL-16) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.